Percutaneous coronary interventions for all patients with complex coronary artery disease: triple vessel disease or left main coronary artery disease. Yes? No? Don't know?

Correspondence: Prof. Patrick Serruys MD, PhD, Head of Interventional Cardiology, Ba583a, Thoraxcentre, Erasmus MC,’s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands E-mail:[email protected] Coronary artery disease remains the leading cause of mortality worldwide. Coronary revascularisation, with either percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG), is advocated when symptoms become uncontrolled despite optimal medical therapy.1 The optimal method of revascularisation in patients with single or double vessel disease rarely needs discussion, with PCI the overwhelming choice. The optimal therapy in those patients with triple vessel disease (3VD) and/or left main stem (LMS) disease however remains subject to continuing heated debate.2,3 The aim of this article is to present, and review the new data for the selection of PCI for these highly complex patients.